BRIEF-U.S. court rules in favor of Depomed in its patent litigation for NUCYNTA
September 30, 2016 at 16:00 PM EDT
* Depomed prevails in Nucynta franchise ANDA litigation providing market exclusivity until December 2025
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.